Evidence map›Paper›PMID 21437932›Full record

Trial reportAnnals of neurology2011

Collaterals dramatically alter stroke risk in intracranial atherosclerosis.

David S Liebeskind, George A Cotsonis, Jeffrey L Saver, Michael J Lynn, Tanya N Turan, Harry J Cloft, Marc I Chimowitz, Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Investigators

Registry-linked trialOpen access · bronzeAbstract readClinical TrialMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Annals of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02479243 (Arterial Spin Labeling MRI Assessment and Quantification of Collateral Circulation in Unilateral Middle Cerebral Artery Atherosclerotic Stenosis), which is not on this map. Cited by 145 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 4 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02479243 unknown statusnot on this mapstarted 2014, after this paper: background citation

Arterial Spin Labeling MRI Assessment and Quantification of Collateral Circulation in Unilateral Middle Cerebral Artery Atherosclerotic Stenosis

Typeobservational_patient_registrySponsorChinese PLA General HospitalRan2014 to 2017Enrolled60ConditionsStroke
3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 4 syntheses or guidelines pooled it, 307 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Use of the neuroform atlas for stenting of intracranial atherosclerotic disease: Clinical and angiographic outcomes.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Article
  13. Review
  14. Article
  15. Stroke risk prediction in symptomatic anterior circulation ICAD: Analysis of regional QMRA flow from the MYRIAD study.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

David S LiebeskindUCLA Stroke Center, Los Angeles, CA 90095, USA. davidliebeskind@yahoo.com
George A Cotsonis
Jeffrey L Saver
Michael J Lynn
Tanya N Turan
Harry J Cloft
Marc I Chimowitz
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Investigators
Emory University · USMedical University of South Carolina · USUCLA Health · USMayo Clinic · US

Funding

ZONA-FREE HAMSTER OVA ASSAY AS AN INDICATOR OF MALE FERTILITYM01RR000425 · NCRR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI ANDERSON, GAIL V · 1985 to 2011
$74.2M
ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BELCHER, HAROLYN MILLICENT EDITH · 1985 to 2007
$37.3M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSIONM01RR000750 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI RODRIGUEZ, HENRY · 1985 to 2008
$25.5M
Zosuquidar trihydrochloride for acute myeloid leukemia &refractory anemiaM01RR000080 · NCRR · UNIVERSITY HOSPITALS OF CLEVELAND · PI DAVIS, PAMELA B · 1985 to 2007
$22.2M
X LINKED NYSTAGMUS SYNDROME WITH FEATURES OF ALBINISMM01RR000039 · NCRR · EMORY UNIVERSITY · PI VACCARINO, VIOLA · 1985 to 2007
$21.3M
WELFARE REFORM AND THE PERINATAL HEALTH OF IMMIGRANTSM01RR000083 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$21.1M
SAMMPRIS (Stenting vs. Aggressive Medical Management for Preventing . . .U01NS058728 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHIMOWITZ, MARC IVOR · 2008 to 2011
$20.0M
UCLA SPOTRIAS CENTER APPLICATION RENEWAL-PROGRAM PROJECTP50NS044378 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VINTERS, HARRY V. · 2003 to 2012
$17.2M
WARFARIN VS ASPIRIN FOR INTRACRANIAL ARTERIAL STENOSISR01NS036643 · NINDS · EMORY UNIVERSITY · PI CHIMOWITZ, MARC IVOR · 1998 to 2002
$9.1M
Collateral Circulation in Acute Ischemic StrokeK23NS054084 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIEBESKIND, DAVID SIGMUND · 2006 to 2010
$764k
Intracranial Stents for Arterial StenosisK24NS050307 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHIMOWITZ, MARC IVOR · 2005 to 2009
$697k
NCATS NIH HHS UL1 TR000454NCRR NIH HHS 5M01 RR000750-32NCRR NIH HHS 5M01 RR00080NCRR NIH HHS M01 RR000039NCRR NIH HHS M01 RR000052NCRR NIH HHS M01 RR000080NCRR NIH HHS M01 RR000083NCRR NIH HHS M01 RR00039NCRR NIH HHS M01 RR000425NCRR NIH HHS M01 RR000750NCRR NIH HHS M01 RR00083-42NCRR NIH HHS M01 RR00425NCRR NIH HHS M01 RR165001NINDS NIH HHS 1R01 NS36643NINDS NIH HHS K23 NS054084NINDS NIH HHS K23NS054084NINDS NIH HHS K24 NS050307NINDS NIH HHS P50 NS044378NINDS NIH HHS P50NS044378NINDS NIH HHS R01 NS036643NINDS NIH HHS R01 NS051688NINDS NIH HHS U01 NS058728
6 · The paper itself

Abstract

objectiveStroke risk due to intracranial atherosclerosis increases with degree of arterial stenosis. We evaluated the previously unexplored role of collaterals in modifying stroke risk in intracranial atherosclerosis and impact on subsequent stroke characteristics.

methodsCollateral flow was graded in blind fashion on 287 of 569 baseline angiograms (stenoses of 50-99% and adequate collateral views) in the Warfarin--Aspirin Symptomatic Intracranial Disease (WASID) trial. Statistical models predicted stroke in the symptomatic arterial territory based on collateral flow grade, percentage of stenosis, and previously demonstrated independent covariates.

resultsAcross all stenoses, extent of collaterals was a predictor for subsequent stroke in the symptomatic arterial territory (hazard ratio [HR] none vs good, 1.14; 95% confidence interval [CI], 0.39-3.30; poor vs good, 4.36; 95% CI, 1.46-13.07; p < 0.0001). For 70 to 99% stenoses, more extensive collaterals diminished risk of subsequent territorial stroke (HR none vs good, 4.60; 95% CI, 1.03-20.56; poor vs good, 5.90; 95% CI, 1.25-27.81; p = 0.0427). At milder degrees of stenoses (50-69%), presence of collaterals was associated with greater likelihood of subsequent stroke (HR none vs good, 0.18; 95% CI, 0.04-0.82; poor vs good, 1.78; 95% CI, 0.37-8.57; p < 0.0001). In multivariate analyses, extent of collaterals was an independent predictor for subsequent stroke in the symptomatic arterial territory (HR none vs good, 1.62; 95% CI, 0.52-5.11; poor vs good, 4.78; 95% CI, 1.55-14.7; p = 0.0019).

interpretationCollateral circulation is a potent determinant of stroke risk in intracranial atherosclerosis, demonstrating a protective role with severe stenoses and identifying more unstable milder stenoses.

Indexed as

AgedCollateral CirculationConstriction, PathologicCoronary AngiographyDouble-Blind MethodFemaleFibrinolytic AgentsHumansIntracranial ArteriosclerosisIschemic Attack, TransientKaplan-Meier EstimateMagnetic Resonance ImagingMaleMeta-Analysis as TopicMiddle AgedProspective StudiesFibrinolytic Agents

Identifiers

PMID21437932
PMCPMC3117968
OpenAlexW71159566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.